- Record: found
- Abstract: not found
- Article: not found
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus : Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
Robert P. Giugliano ,
Christopher P. Cannon ,
Michael A. Blazing ,
José C. Nicolau ,
Ramón Corbalán ,
Jindřich Špinar ,
Jeong-Gun Park ,
Jennifer A. White ,
Erin A. Bohula ,
Eugene Braunwald
April 09 2018
December 20 2017
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Ezetimibe, when added to simvastatin, reduces cardiovascular events after acute coronary
syndrome. We explored outcomes stratified by diabetes mellitus (DM).